Collections and calls for papers

To mark the 60th anniversary of the first clinical use of metformin for diabetes, Diabetologia has commissioned a series of articles on the many evolving (and controversial) aspects of metformin use. To begi...

Type 2 diabetes, once considered a disease of old age, sadly now occurs not uncommonly in children and young adults. Diabetes thus affects everyone, from cradle to grave, and thus we have chosen ‘A life cour...

There is currently significant attention surrounding glucose-lowering drugs based on incretins, a group of hormones released from the intestine that play a vital role in regulating whole-body glucose metabol...

Diabetologia is excited to announce its 2021 special issue: Celebrating 100 years of insulin. Reviews in this issue describe events related to the discovery of insulin, complications of insulin use and futur...

The 2022 special issue of Diabetologia highlights advances in precision medicine in diabetes research and care. It has long been clear that the ability to collect large data sets and to analyse them quickly ...

This special series of reviews focuses on the newest class of glucose-lowering agents, the sodium–glucose cotransporter (SGLT) inhibitors. Rieg and Vallon begin the series by tracing the development of the S...

Regular exercise is known to improve insulin sensitivity and metabolic health in people with type 1 and type 2 diabetes, but how exactly does it do this and how should these individuals exercise? We have com...